A third-line antiretroviral therapy register to track patient clinical and virological outcomes
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i8.16695Keywords:
ART, virological outcomesAbstract
-
References
Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV & AIDS statistics – fact sheet 2021. https://www.unaids.org/en/resources/ fact-sheet#:~:text=GLOBAL%20HIV%20STATISTICS,infected%20with%20 HIV%20in%202020 (accessed 13 July 2022).
Moorhouse M, Maartens G, Venter WDF, et al. Third-line antiretroviral therapy program in the South African public sector: Cohort description and virological outcomes. J Acquir Immune Defic Syndr 2019;80(1):73-78. https:// doi.org/10.1097/QAI.0000000000001883
Venter W, Kaiser B, Pillay Y, et al. Cutting the cost of South African antiretroviral therapy using newer, safer drugs. S Afr Med J 2017;107(1):28-30. https://doi. org/10.7196/SAMJ.2016.v107.i1.12058
National Department of Health, South Africa. National consolidated guidelines for the management of HIV in adults, adolescents, children and infants and prevention of mother-to-child transmission. 2020. https://www.knowledgehub. org.za/elibrary/national-consolidated-guidelines-management-hiv-adults- adolescents-children-and-infants (accessed 13 July 2022).
Fox MP, Berhanu R, Steegen K, et al. Intensive adherence counselling for HIV‐ infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa. Trop Med Int Health 2016;21(9):1131-1137. https://doi. org/10.1111/tmi.12741
Kouamou V, Manasa J, Katzenstein D, McGregor AM, Ndhlovu CE, Makadzange AT. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy. AIDS 2019;33(11):1729-1737. https://doi.org/10.1097/QAD.0000000000002284
National Department of Health, South Africa. Master Health Product List, January 2019. https://www.health.gov.za/tenders/ (current version, 1 July 2022). 8. Gliklich RE, Dreyer NA, Leavy MB, eds. Registries for evaluating patient outcomes: A user’s guide. 3rd ed. Rockville, Md.: Agency for Healthcare Research and Quality, 2014. Report No. 13(14)-EHC111. PMID: 24945055.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
